Antiepileptic Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antiepileptic Drugs Market to 2027 - Global Analysis and Forecasts by Drug Class (First Generation, Second Generation, Third Generation); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00004426 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antiepileptic drugs are primary treatment type for patients suffering with epilepsy. These medications help to stop seizures among epileptic patients at a significant rate. Some of the medications are taken as a "course of treatment" to fight against epileptic seizures, however these drugs are only preventive form of medication to avoid seizures.

MARKET DYNAMICS
The antiepileptic drugs market is anticipated to grow in the forecast, owing to rising prevalence of epilepsy and increasing number of drugs in pipeline. In addition, development of novel drugs that can show effective results in curing epilepsy completely is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Antiepileptic Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of antiepileptic drugs market with detailed market segmentation by drug class, distribution channel and geography. The global antiepileptic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antiepileptic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antiepileptic drugs market is segmented on the basis of by drug class and distribution channel. Based on drug class, the market is segmented as, first generation, second generation, third generation. Based on distribution channel, the market is segmented in to hospital pharmacies, and retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antiepileptic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antiepileptic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antiepileptic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antiepileptic drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the antiepileptic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from antiepileptic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antiepileptic drugs market in the global market. Below mentioned is the list of few companies engaged in the antiepileptic drugs market.

The report also includes the profiles of key antiepileptic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services, Inc.
  • Abbott
  • Bausch Health Companies Inc.
  • Pfizer, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Novartis AG
  • UCB S.A.
  • Eisai Co., Ltd.
  • Otsuka Holdings Co., Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiepileptic Drugs Market - By Drug Class
1.3.2 Antiepileptic Drugs Market - By Distribution Channel
1.3.3 Antiepileptic Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIEPILEPTIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIEPILEPTIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIEPILEPTIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIEPILEPTIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIEPILEPTIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIEPILEPTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION
7.3.1. Overview
7.3.2. First Generation Market Forecast and Analysis
7.4. SECOND GENERATION
7.4.1. Overview
7.4.2. Second Generation Market Forecast and Analysis
7.5. THIRD GENERATION
7.5.1. Overview
7.5.2. Third Generation Market Forecast and Analysis
8. ANTIEPILEPTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
9. ANTIEPILEPTIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antiepileptic Drugs Market Overview
9.1.2 North America Antiepileptic Drugs Market Forecasts and Analysis
9.1.3 North America Antiepileptic Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antiepileptic Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Antiepileptic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antiepileptic Drugs Market
9.1.5.1.1 United States Antiepileptic Drugs Market by Drug Class
9.1.5.1.2 United States Antiepileptic Drugs Market by Distribution Channel
9.1.5.2 Canada Antiepileptic Drugs Market
9.1.5.2.1 Canada Antiepileptic Drugs Market by Drug Class
9.1.5.2.2 Canada Antiepileptic Drugs Market by Distribution Channel
9.1.5.3 Mexico Antiepileptic Drugs Market
9.1.5.3.1 Mexico Antiepileptic Drugs Market by Drug Class
9.1.5.3.2 Mexico Antiepileptic Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Antiepileptic Drugs Market Overview
9.2.2 Europe Antiepileptic Drugs Market Forecasts and Analysis
9.2.3 Europe Antiepileptic Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antiepileptic Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Antiepileptic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antiepileptic Drugs Market
9.2.5.1.1 Germany Antiepileptic Drugs Market by Drug Class
9.2.5.1.2 Germany Antiepileptic Drugs Market by Distribution Channel
9.2.5.2 France Antiepileptic Drugs Market
9.2.5.2.1 France Antiepileptic Drugs Market by Drug Class
9.2.5.2.2 France Antiepileptic Drugs Market by Distribution Channel
9.2.5.3 Italy Antiepileptic Drugs Market
9.2.5.3.1 Italy Antiepileptic Drugs Market by Drug Class
9.2.5.3.2 Italy Antiepileptic Drugs Market by Distribution Channel
9.2.5.4 Spain Antiepileptic Drugs Market
9.2.5.4.1 Spain Antiepileptic Drugs Market by Drug Class
9.2.5.4.2 Spain Antiepileptic Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Antiepileptic Drugs Market
9.2.5.5.1 United Kingdom Antiepileptic Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Antiepileptic Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antiepileptic Drugs Market Overview
9.3.2 Asia-Pacific Antiepileptic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Antiepileptic Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antiepileptic Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Antiepileptic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antiepileptic Drugs Market
9.3.5.1.1 Australia Antiepileptic Drugs Market by Drug Class
9.3.5.1.2 Australia Antiepileptic Drugs Market by Distribution Channel
9.3.5.2 China Antiepileptic Drugs Market
9.3.5.2.1 China Antiepileptic Drugs Market by Drug Class
9.3.5.2.2 China Antiepileptic Drugs Market by Distribution Channel
9.3.5.3 India Antiepileptic Drugs Market
9.3.5.3.1 India Antiepileptic Drugs Market by Drug Class
9.3.5.3.2 India Antiepileptic Drugs Market by Distribution Channel
9.3.5.4 Japan Antiepileptic Drugs Market
9.3.5.4.1 Japan Antiepileptic Drugs Market by Drug Class
9.3.5.4.2 Japan Antiepileptic Drugs Market by Distribution Channel
9.3.5.5 South Korea Antiepileptic Drugs Market
9.3.5.5.1 South Korea Antiepileptic Drugs Market by Drug Class
9.3.5.5.2 South Korea Antiepileptic Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antiepileptic Drugs Market Overview
9.4.2 Middle East and Africa Antiepileptic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Antiepileptic Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antiepileptic Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Antiepileptic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antiepileptic Drugs Market
9.4.5.1.1 South Africa Antiepileptic Drugs Market by Drug Class
9.4.5.1.2 South Africa Antiepileptic Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Antiepileptic Drugs Market
9.4.5.2.1 Saudi Arabia Antiepileptic Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Antiepileptic Drugs Market by Distribution Channel
9.4.5.3 U.A.E Antiepileptic Drugs Market
9.4.5.3.1 U.A.E Antiepileptic Drugs Market by Drug Class
9.4.5.3.2 U.A.E Antiepileptic Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antiepileptic Drugs Market Overview
9.5.2 South and Central America Antiepileptic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Antiepileptic Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antiepileptic Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Antiepileptic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antiepileptic Drugs Market
9.5.5.1.1 Brazil Antiepileptic Drugs Market by Drug Class
9.5.5.1.2 Brazil Antiepileptic Drugs Market by Distribution Channel
9.5.5.2 Argentina Antiepileptic Drugs Market
9.5.5.2.1 Argentina Antiepileptic Drugs Market by Drug Class
9.5.5.2.2 Argentina Antiepileptic Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIEPILEPTIC DRUGS MARKET, KEY COMPANY PROFILES
11.1. GLAXOSMITHKLINE PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. JOHNSON & JOHNSON SERVICES, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ABBOTT
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAUSCH HEALTH COMPANIES INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PFIZER, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SUNOVION PHARMACEUTICALS INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. UCB S.A.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. EISAI CO., LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. OTSUKA HOLDINGS CO., LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline Plc
2. Johnson & Johnson Services, Inc.
3. Abbott
4. Bausch Health Companies Inc.
5. Pfizer, Inc.
6. Sunovion Pharmaceuticals Inc.
7. Novartis AG
8. UCB S. A.
9. Eisai Co. , Ltd.
10. Otsuka Holdings Co. , Ltd.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book